Skip to main content
Article thumbnail
Location of Repository

TCF7L2 Regulates Late Events in Insulin Secretion From Pancreatic Islet β-Cells

By Gabriela da Silva Xavier, Merewyn K. Loder, Angela McDonald, Andrei I. Tarasov, Raffaella Carzaniga, Katrin Kronenberger, Sebastian Barg and Guy A. Rutter
Topics: Original Article
Publisher: American Diabetes Association
OAI identifier: oai:pubmedcentral.nih.gov:2661588
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2008). A genome-wide RNAi screen for Wnt/ -catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc Natl Acad Sci 105:9697–9702,
    2. (2004). A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5:691–701,
    3. (2002). B: Down-regulated expression of exocytotic proteins in pancreatic islets of diabetic GK rats.
    4. (1999). Blockade of membrane transport and disassembly of the Golgi complex by expression of syntaxin 1A in neurosecretion-incompetent cells: prevention by rbSEC1.
    5. (2000). C: A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance.
    6. (2006). Ca2 microdomains and the control of insulin secretion. Cell Calcium 40:539–551,
    7. (2000). CB: Isolation of INS-1-derived cell lines with robust ATP-sensitive K channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:424–430,
    8. (1998). Clevers H: Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19:379–383,
    9. (2007). CN: Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
    10. (2002). Eliasson L: Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic B-cells. Pflugers Arch 444:43–51,
    11. FB: Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of US women and men.
    12. (2008). Fritsche A: Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 51:597–601,
    13. (2007). Froguel P: A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885,
    14. (2006). Froguel P: Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 55:2903–2908,
    15. (2000). GA: Acute overexpression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes 49:1149–1155,
    16. (2005). GA: Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells.
    17. (2004). GA: Mechanisms of dense core vesicle recapture following ‘kiss and run’ (‘cavicapture’) exocytosis in insulinsecreting cells.
    18. (2005). Gaisano HY: Transgenic mouse overexpressing syntaxin-1A as a diabetes model. Diabetes 54:2744–2754,
    19. (2007). Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336,
    20. (2007). Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657–662,
    21. (2001). Global and societal implications of the diabetes epidemic.
    22. (2007). Groop L: Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
    23. (2007). Hattersley AT: Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336–1341,
    24. (2001). Hegele RA: Genetic determinants of type 2 diabetes mellitus. Clin Genet 60:243–254,
    25. (2006). Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes 55:435–440,
    26. (2008). JD: Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiol Biomarkers Prev 17:978–982,
    27. (2008). Maedler K: TCF7L2 regulates cell survival and function in human pancreatic islets. Diabetes 57:645–653,
    28. (2007). McCarthy MI: TCF7L2: the biggest story in diabetes genetics since HLA? Diabetologia 50:1–4,
    29. (2009). MI: Association analysis of 6736 UK subjects provides replication and confirms
    30. (2007). Ong KK, O’Rahilly S, Wareham NJ: TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes 56:1943–1947,
    31. (2007). PA: Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia 50:1621–1630,
    32. (2008). Parton LE: The beta-cell in type 2 diabetes and in obesity. Front Horm Res 36:118–134,
    33. Renstro ¨m E, Rorsman P: Large dense-core vesicle exocytosis in pancreatic [beta]-cells monitored by capacitance measurements.
    34. (2006). Seve M: In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion.
    35. (2006). SP: Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction. Mol Cell Biol 26:929–939,
    36. (2006). Stefansson K: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320–323,
    37. (2007). Sudhof TC: Dual modes of Munc18-1/SNARE interactions are coupled by functionally critical binding to syntaxin-1 N terminus.
    38. (2004). T: Protein kinase activation increases insulin secretion by sensitizing the secretory machinery to Ca2.
    39. (1998). Thomas AP: Integrating cytosolic calcium signals into mitochondrial metabolic responses.
    40. (1996). Tornheim K: Temporal patterns of changes in ATP/ADP ratio, glucose 6-phosphate and cytoplasmic free Ca2 in glucose-stimulated pancreatic beta-cells.
    41. (2007). Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 50:1192–1200,
    42. (1992). Wainscoat JS: Linkage of type 2 diabetes to the glucokinase gene. Lancet 339:1307–1310,
    43. (1992). Wainscoat JS: Missense glucokinase mutation in maturityonset diabetes of the young and mutation screening in late-onset diabetes.
    44. (1990). Yamamura K: Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126–132,

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.